Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Cancers|July 24, 2021
Advances in Immunotherapy for Adult GlioblastomaChirayu R Chokshi, Benjamin A Brakel, Nazanin Tatari, et al.Molecular Imaging and Biology|May 22, 2025
Targeted Radionuclide Therapy Using a Lutetium-177 Labeled Human Anti-CD133 AntibodyKevin Wyszatko, Nancy Janzen, Napoleon Law, et al.Oncogene|November 8, 2019
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cellsBranavan Manoranjan, Chirayu Chokshi, Chitra Venugopal, et al.Scientific Reports|October 16, 2025
CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastomaNeil Savage, Etienne Danis, Chirayu R Chokshi, et al.Frontiers in Immunology|July 25, 2022
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid TumorsNazanin Tatari, Xiaoyu Zhang, Shawn C Chafe, et al.Journal of Neuro-Oncology|June 24, 2023
An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastomaAshley A Adile, David Bakhshinyan, Yujin Suk, et al.Acta Neuropathologica|November 26, 2024
Functional profiling of murine glioma models highlights targetable immune evasion phenotypesNicholas Mikolajewicz, Nazanin Tatari, Jiarun Wei, et al.Cancer Research|June 28, 2018
Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent GlioblastomaMaleeha A Qazi, Parvez Vora, Chitra Venugopal, et al.Proceedings of the National Academy of Sciences of the United States of America|February 13, 2023
An HLA-G/SPAG9/STAT3 axis promotes brain metastasesBlessing Iquo Bassey-Archibong, Chirayu Rajendra Chokshi, Nikoo Aghaei, et al.Journal for Immunotherapy of Cancer|January 12, 2022
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironmentMathieu Seyfrid, William Thomas Maich, Vaseem Muhammad Shaikh, et al.Pageof 3